RxSight Light Adjustable Lens; Light Delivery Device
Rxsight, Inc. · Decision date Jun 8, 2026
What did the FDA approve?
FDA records P160055/S055 as a supplement to PMA P160055, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jun 8, 2026.
FDA approval order statement
approval for a change in the routine Ethylene Oxide sterilization process parameters, specifically a reduction in the Ethylene Oxide gas concentration used to terminally sterilize the subject devices
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Ophthalmic
- Decision date
- Jun 8, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P160055/S055
- Regulatory pathway
- PMA supplement
- Applicant
- Rxsight, Inc.
- Product code
- PZK
- Decision code
- APPR
- Decision date
- Jun 8, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Light adjustable lens (LAL) and light delivery device (LDD).
- Applicant
- Rxsight, Inc.
- Product code
- PZK
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P160055. Subsequent supplements may change the device or its indications.
FDA decision timeline
P160055 · Original PMA
LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)
P160055/S045 · Related supplement
LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)
P160055/S052 · Related supplement
Light Adjustable Lens and Light Delivery Device
P160055/S055 received
Application receipt date recorded by FDA.
P160055/S055 · FDA decision
Real-Time Process
P160055/S054 · Related supplement
RxSight Light Adjustable Lens; Light Delivery Device
P160055/S056 · Related supplement
RxSight Light Adjustable Lens and Light Delivery Device
P160055/S058 · Related supplement
RxSight Light Adjustable Lens and Light Delivery Device
P160055/S057 · Related supplement
RxSight Light Adjustable Lens and Light Delivery Device
Timeline entries are records held by MedtechLedger for P160055. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160055
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Rxsight, Inc. | PMA approval | Nov 22, 2017 | FDA | |
| Rxsight, Inc. | PMA supplement | Sep 2, 2025 | FDA | |
Light Adjustable Lens and Light Delivery DeviceP160055/S052 | Rxsight, Inc. | PMA supplement | Oct 8, 2025 | FDA |
| Rxsight, Inc. | PMA supplement | Jun 26, 2026 | FDA | |
| Rxsight, Inc. | PMA supplement | Sep 3, 2026 | FDA | |
| Rxsight, Inc. | PMA supplement | Oct 22, 2026 | FDA | |
| Rxsight, Inc. | PMA supplement | Nov 5, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Rxsight, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 100 Columbia, Aliso Viejo, CA, 92656
Sources and methodology
- Original FDA record: P160055/S055
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




